Income Portfolio: Why We Sold AbbVie To Buy AT&T
Summary: This trade increases this position’s yield by over 200 basis points while lowering risk
Summary: This trade increases this position’s yield by over 200 basis points while lowering risk
Summary: AbbVie is a global biopharmaceutical company with a large portfolio of drugs and therapies.
Summary: While 3M has lost about 29% of its market value year-to-date, we still believe
Summary: Micron Technology and NVIDIA have both taken hits this year. Weakness in chip demand
Summary: Like many banks, Bank of America outperformed on net interest income and pre-provision profits
Summary: 3M posted poor results for the third quarter, even relative to low expectations, as
Summary: Due to the hiked heating oil & natural gas prices and colder temperatures this
Summary: Comcast Corporation’s Q3 results were better than expected – as the company topped analyst
Summary: Comcast stock has fallen back to what it was five years ago, and now
Summary: Eli Lilly and Company is fairly new to the dividend growth club. The company